# FDA Inspection 1221161 - Telomerix Stem Cell Biobank LLC - September 13, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/telomerix-stem-cell-biobank-llc/de88a744-74db-4833-9b89-e26abfa11777
Source feed: FDA_Inspections

> FDA Inspection 1221161 for Telomerix Stem Cell Biobank LLC on September 13, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221161
- Company Name: Telomerix Stem Cell Biobank LLC
- Inspection Date: 2023-09-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1221161 - 2023-09-13](https://www.globalkeysolutions.net/records/fda_inspections/telomerix-stem-cell-biobank-llc/e9ac67ec-484e-47c1-8623-9ce5e80fe9f6)

Company: https://www.globalkeysolutions.net/companies/telomerix-stem-cell-biobank-llc/03787c90-b45f-42dc-8b0a-38e75da3a92f

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d